Nasasbiotech is a biotechnology company dedicated to developing innovative clinical solutions for cancer diagnosis, prognosis, and treatment. Our focus on liquid biopsy technologies aims to revolutionize oncology by addressing the challenges of metastasis, which accounts for 90% of cancer-related deaths. Our solutions, crafted in collaboration with oncologists, are designed to meet the critical needs of the medical community.

As a spin-off from the Translational Medical Oncology Laboratory of the Health Research Institute of Santiago de Compostela (IDIS), Nasasbiotech has a strong foundation in biomedicine research. Our pioneering work includes studying circulating tumor cells (CTCs) and developing cutting-edge systems for their capture and control. We have successfully created a prototype cell capture medical device with support from SERGAS and Fundación Barrié, bringing us closer to our goal of transforming cancer care.

For more information about our developments, contact us today